Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A study of the safety of ramelteon in elderly subjects.

Trial Profile

A study of the safety of ramelteon in elderly subjects.

Phase of Trial: Phase IV

Latest Information Update: 09 Jun 2013

At a glance

  • Drugs Ramelteon (Primary) ; Zolpidem
  • Indications Insomnia
  • Focus Pharmacodynamics
  • Sponsors Takeda Global Research and Development Center
  • Most Recent Events

    • 12 Jun 2008 The actual completion date has changed from Feb 2007 to Sep 2006 as reported by ClinicalTrials.gov.
    • 25 Dec 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top